Promoting early detection tests for colorectal carcinoma and adenomatous polyps

Abstract

BACKGROUNDThe purpose of the current study was to provide health professionals, professional organizations, policy makers, and the general public with a practical blueprint for increasing the practice of screening for colorectal carcinoma (CRC) and adenomatous polyps over the next decade. The National Colorectal Cancer Roundtable (NCCRT) was founded in 1997 by the American Cancer Society and the Centers for Disease Control and Prevention to provide strategic leadership, advocacy, long‐range planning, and coordination of interventions targeted at reducing the disease burden of CRC through education, early detection, and prevention. The NCCRT and its three workgroups include CRC survivors; recognized experts in primary care, gastroenterology, radiology, colorectal surgery, nursing, public policy, epidemiology, and behavioral science; patient advocates; and representatives of health plans and insurers, government, and other organizations.METHODSThe NCCRT performed a literature review of published and unpublished data related to CRC screening guidelines, compliance, and barriers to adherence, as well as test effectiveness and cost‐effectiveness. Members of the three NCCRT workgroups developed summary reports regarding professional education, public education and awareness, and health policy. A drafting committee developed the final strategic plan from workgroup reports, which was reviewed by the entire NCCRT membership, amended, and subsequently approved in final form.RESULTS AND CONCLUSIONSAlthough the rationale for population‐wide CRC screening is well established, the majority of adults in the U.S. are not currently being screened for CRC. Thus, the nation foregoes an opportunity to reduce CRC‐related mortality by an estimated ≥ 50%. To increase CRC screening rates, the issues of patient and physician barriers to screening, lack of universal coverage, lack of incentives to motivate adherence, and expanded infrastructure must be addressed. Cancer 2002;95:1618–28. © 2002 American Cancer Society.DOI 10.1002/cncr.10890

The Impact of a Novel Computer-Based Decision Aid on Shared Decision Making for Colorectal Cancer Screening

“…Second, it provides an overview of CRC and CRC screening that incorporates key messages endorsed by the National Colorectal Cancer Roundtable to heighten awareness and entice interest in screening. 36 Third, one version also incorporates the YDR risk assessment tool to enable users to incorporate personalized risk estimates into their decision-making. Of note, however, we observed no significant associations between personalized risk feedback and patient preferences or other outcomes of interest.…”

“…The content was derived from key messages endorsed by the National Colorectal Cancer Roundtable 36 and Massachusetts Department of Public Health 37 for public education. Cumulative knowledge scores (range, 0–12) were derived by summing correct responses to the 12 individual knowledge questions.…”

Process Evaluation of Cancer Prevention Media Campaigns in Appalachian Ohio

“…Thus, our campaign materials were culturally appropriate and our messages resonated with residents. The CRC screening campaign focused on promoting CRC screening awareness and activated community members to talk to their provider about screening as suggested by the National Colorectal Cancer Roundtable (Levin et al, 2002), and the F&V campaign focused on promoting a healthy lifestyle. Exposure to campaign materials was evaluated using a mailed survey so images of real, fake, and contamination billboards and real and fake posters could be included in the survey to improve accuracy in reporting sightings of real materials and to check for contamination (Slater & Kelly, 2002).…”

A Cost Analysis of Colonoscopy using Microcosting and Time-and-motion Techniques

“…In particular, population-level cost-effectiveness and cost-utility analyses should adopt the societal perspective. The societal perspective also highlights the contribution of patients' and caregivers' time, which are important barriers to achieving high colorectal cancer screening rates 21 . Previous estimates of colonoscopy cost 8,13,[22][23][24] have used an institutional perspective that did not measure direct nonhealth care or patient time costs.…”